From Seekingalpha · SA Transcripts · · 30s
PDS Biotechnology Discusses PDS-0301 for Metastatic Colorectal Cancer
PDS Biotechnology Corporation details PDS-0301 immunocytokine's role in treating metastatic colorectal cancer.
In brief
PDS Biotechnology Corporation details PDS-0301 immunocytokine's role in treating metastatic colorectal cancer. PDS Biotechnology Corporation discussed PDS-0301 immunocytokine's potential for metastatic colorectal cancer treatment. Originally reported by Seekingalpha.
PDS Biotechnology Corporation
PDS Biotechnology Corporation published a slide deck discussing PDS-0301 immunocytokine's role in treating metastatic colorectal cancer.
Slide Deck Published
The slide deck was created by PDS Biotechnology Corporation in conjunction with this event.
Transcripts Team
Seeking Alpha's transcripts team is responsible for developing quarterly earnings calls and expanding coverage.
What matters most
PDS Biotechnology Corporation discussed PDS-0301 immunocytokine's potential for metastatic colorectal cancer treatment.
